GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gabather AB (OSTO:GABA) » Definitions » Ending Cash Position

Gabather AB (OSTO:GABA) Ending Cash Position : kr0.88 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Gabather AB Ending Cash Position?

Gabather AB's Ending Cash Position for the quarter that ended in Dec. 2024 was kr0.88 Mil.

Gabather AB's quarterly Ending Cash Position increased from Jun. 2024 (kr0.99 Mil) to Sep. 2024 (kr2.13 Mil) but then declined from Sep. 2024 (kr2.13 Mil) to Dec. 2024 (kr0.88 Mil).

Gabather AB's annual Ending Cash Position declined from Dec. 2022 (kr6.27 Mil) to Dec. 2023 (kr1.12 Mil) and declined from Dec. 2023 (kr1.12 Mil) to Dec. 2024 (kr0.88 Mil).


Gabather AB Ending Cash Position Historical Data

The historical data trend for Gabather AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gabather AB Ending Cash Position Chart

Gabather AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.92 14.85 6.27 1.12 0.88

Gabather AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.12 2.37 0.99 2.13 0.88

Gabather AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Gabather AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.115+-0.237
=0.88

Gabather AB's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.132+-1.254
=0.88


Gabather AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Gabather AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Gabather AB Business Description

Traded in Other Exchanges
N/A
Address
Forskargatan 20J, Byggn 215 N, Sodertalje, SWE, 151 36
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.

Gabather AB Headlines

No Headlines